Interactions of Body Weight Loss with Lipophilic Toxin Storage: Commentary.

OA: gold CC-BY-4.0
⚙ AI-generated summary by qwen3.7-flash, 2026-08-26 ⓘ

This commentary highlights that rapid weight loss mobilizes lipophilic toxins from adipose tissue into the blood, potentially exposing vital organs, and discusses elimination strategies using nondigestible fats or lipase inhibitors.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-08-22 · read from full text ⓘ

This commentary explores the complex interactions between body weight loss and the mobilization of lipophilic toxins stored in adipose tissue. The authors discuss how reductions in body mass can lead to the release of these environmental pollutants into the bloodstream, potentially affecting metabolic health. They highlight that while weight loss is generally beneficial, the transient increase in circulating toxin levels warrants careful consideration in clinical and public health contexts. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

A high incidence of obesity and surplus body fat has been observed in wealthy countries for many decades. It is generally recognized that these excesses contribute to serious disease states, including type 2 diabetes and cardiovascular diseases. On the other hand, the adipose tissue stores relatively safely many environmental lipophilic toxins. However, rapid weight loss mobilizes these toxins to the blood to be exposed to vital organs, such as the brain, lungs, and others. With the introduction of potent diabetic drugs causing rapid weight reduction, the question of mobilization of lipophilic toxins to the blood should be considered. In this commentary, we raised this mobilization of adipose tissue toxins to the readers. Also, we discussed how these toxins may be eliminated from the body through the use of nondigestible fat, such as olestra or lipase inhibitors, such as Xenical.
Full text 565 characters · extracted from pmc-nxml · 1 sections · click to expand

Author

The authors’ responsibilities were as follows – RJ, ML, PT: contributed equally to the writing, editing, and finalizing of this commentary; had numerous discussions before the writing of the commentary and later regarding the content of this commentary; read the rebuttal to the reviewers' comments, the modified commentary as well as the acknowledgment; and approved the revision and their initials represent their approval of the revision and the revised paper. The authors report no conflicts of interest. The authors reported no funding received for this study.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: pmc-nxml ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-09-27T09:11:36.575535+00:00
License: CC-BY-4.0 · commercial use OK · attribution required
Per Europe PMC